Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients. - Université de Lorraine Accéder directement au contenu
Article Dans Une Revue Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology Année : 2002

Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.

Résumé

As conflicting results have been observed by some authors in liver recipients, the aim of the study was to evaluate lamivudine therapy in 3 groups of patients with chronic hepatitis B: non-transplanted patients, liver and kidney recipients.
Fichier non déposé

Dates et versions

hal-02014614 , version 1 (11-02-2019)

Identifiants

  • HAL Id : hal-02014614 , version 1
  • PUBMED : 11938042

Citer

Evelyne Schvoerer, Imed Kabissa, Emmanuelle Cotto, Anne-Christine Jouvencel, Charles Balabaud, et al.. Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.. Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology, 2002, 26 (1), pp.62-6. ⟨hal-02014614⟩

Collections

UNIV-LORRAINE
28 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More